Severino Michael insider trades
Severino Michael has filed 15 Form 4s with the SEC that we hold, for AbbVie Inc. (ABBV) (Vice Chairman), Avantor, Inc. (AVTR) (Director), Viatris Inc (VTRS) (Director) and Sarepta Therapeutics, Inc. (SRPT) (Chief Executive Officer, Director). Across all of them we count 0 purchases worth $0 and 17 sales worth $88.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 68,196 shares of AbbVie Inc. worth $10.3M, dated 2022-05-23. The first filing on our record is dated 2021-12-30 and the latest 2026-07-29.
AbbVie Inc. (ABBV)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-06 | S, sale reported on Form 4 | 40,176 | $6.0M | 2022-05-10 |
| 2022-05-06 | S, sale reported on Form 4 | 45,988 | $7.0M | 2022-05-10 |
| 2022-05-06 | S, sale reported on Form 4 | 13,836 | $2.1M | 2022-05-10 |
| 2022-05-09 | S, sale reported on Form 4 | 47,215 | $7.1M | 2022-05-10 |
| 2022-05-09 | S, sale reported on Form 4 | 31,714 | $4.8M | 2022-05-10 |
| 2022-05-09 | S, sale reported on Form 4 | 21,071 | $3.2M | 2022-05-10 |
| 2022-05-10 | S, sale reported on Form 4 | 28,536 | $4.3M | 2022-05-10 |
| 2022-05-10 | S, sale reported on Form 4 | 48,591 | $7.4M | 2022-05-10 |
| 2022-05-10 | S, sale reported on Form 4 | 22,873 | $3.5M | 2022-05-10 |
| 2022-05-16 | S, sale reported on Form 4 | 400 | $62.2K | 2022-05-18 |
| 2022-05-16 | S, sale reported on Form 4 | 46,273 | $7.1M | 2022-05-18 |
| 2022-05-16 | S, sale reported on Form 4 | 53,327 | $8.3M | 2022-05-18 |
| 2022-05-17 | S, sale reported on Form 4 | 2,100 | $326.1K | 2022-05-18 |
| 2022-05-17 | S, sale reported on Form 4 | 43,621 | $6.7M | 2022-05-18 |
| 2022-05-17 | S, sale reported on Form 4 | 54,279 | $8.4M | 2022-05-18 |
| 2022-05-23 | S, sale reported on Form 4 | 68,196 | $10.3M | 2022-05-25 |
| 2022-05-23 | S, sale reported on Form 4 | 11,605 | $1.8M | 2022-05-25 |
Avantor, Inc. (AVTR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Viatris Inc (VTRS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Sarepta Therapeutics, Inc. (SRPT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1609447) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms